| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 235.1 | 224.4 | 189.8 |
| Other income | -1.9 | 14.3 | 1.4 |
| Total income | 233.2 | 238.7 | 191.3 |
| Profit before exceptional items & tax | 49.5 | 87.5 | 78.7 |
| Profit before tax | 49.5 | 87.5 | 78.7 |
| Net profit | 36.6 | 65.9 | 58.8 |
| Operating margin | 21.2% | 36.7% | 41.1% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -37.80% |
|---|---|
| Net profit, quarter on quarter | -44.50% |
| Revenue, year on year | +23.90% |
| Operating profit, year on year | -33.50% |
| Operating profit, quarter on quarter | -29.80% |
BSE results filing, NSE: JSLL. Figures extracted from the filing.
Jeena Sikho Lifecare Ltd: key numbers
- Share price
- ₹294.75
- Market cap
- ₹3,664 Cr
- Revenue (annual)
- ₹801.4 Cr
- Net profit (annual)
- ₹221.8 Cr
- P/E (TTM)
- 17.1×Sector 48.6×
- Promoter holding
- 63.67%+0.05% QoQ
- FII holding
- 4.49%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jeena Sikho Lifecare Ltd
All →Jeena Sikho Lifecare Capacity Expansion
Jeena Sikho Lifecare began operations at a new 17,700 sq ft client support centre in Noida effective November 18, 2026. The facility expands its healthcare service network.
- client support centre area
- 17700.0 sq ft
Jeena Sikho Lifecare Earnings Call Transcript: Key Takeaways
Management admitted Q2 was a 'failed experiment' where aggressive e-commerce expansion and celebrity branding burn cannibalized high-margin hospital services, causing significant margin contraction despite steady revenue growth.
- Call
- Guides 25% growth
Jeena Sikho Lifecare Product Launch
Jeena Sikho Lifecare launched ten new Ayurvedic healthcare products in the domestic market on November 11, 2026. The filing gives product-wise details under SEBI product-launch disclosure rules.
Jeena Sikho Lifecare Merger & Restructuring Worth ₹0.03 Cr
Jeena Sikho Lifecare's board approved incorporating Ayugenomics Private Limited as a subsidiary, holding 60%. The company will invest Rs 3 lakh, subject to statutory approvals.
- Value
- ₹0.03 Cr
Jeena Sikho Lifecare Board Meeting Date
Jeena Sikho Lifecare has scheduled a board meeting for 14 Nov 2026 to consider unaudited Q1 FY27 financial results. The trading window is closed from 1 Oct to 16 Nov 2026.
Jeena Sikho Lifecare Other Announcement
Jeena Sikho Lifecare Ltd filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as per regulatory requirements.